Dissecting stromal-epithelial interactions in a 3D invitro cellularized intestinal model for permeability studies

Biomaterials

Volumn 56, Issue , 2015, Pages 36-45

  Pereira, Carla ^a,b   Araújo, Francisca ^a,b   Barrias, Cristina C ^a   Granja, Pedro L ^a,b   Sarmento, Bruno ^a,c  

^a UNIVERSITY OF PORTO   (Portugal)

^b UNIVERSITY OF PORTO   (Portugal)

^c UNIVERSITY INSTITUTE OF HEALTH SCIENCES IUCS   (Portugal)

Author keywords

Caco 2 cells; Extracellular matrix (ECM); Fibroblast; HT29 MTX cells; Intestinal mucosa; Triple co culture

Indexed keywords

DRUG PRODUCTS; FIBROBLASTS; INSULIN;

CACO-2 CELLS; CELL CULTURE MODELS; CO-CULTURES; EFFICIENT PREDICTIONS; EXTRACELLULAR MATRICES; INTESTINAL MUCOSA; MODEL ARCHITECTURE; THREEDIMENSIONAL (3-D);

ANIMAL CELL CULTURE;

INSULIN; MATRIGEL; FIBRONECTIN;

ANIMAL CELL; ARTICLE; CACO 2 CELL LINE; CELL CULTURE; CELL INTERACTION; CONTROLLED STUDY; EPITHELIUM CELL; FEASIBILITY STUDY; HT 29 CELL LINE; IN VITRO STUDY; INTESTINE CELL; INTESTINE MUCOSA; INTESTINE MUCOSA PERMEABILITY; LAMINA PROPRIA; MOUSE; MYOFIBROBLAST; NONHUMAN; PRIORITY JOURNAL; STROMA; STROMAL EPITHELIAL INTERACTION; CELL CULTURE TECHNIQUE; CELL PROLIFERATION; CHEMISTRY; COCULTURE; CYTOLOGY; HUMAN; INTESTINE; INTESTINE ABSORPTION; METABOLISM; PATHOLOGY; PERMEABILITY; PROCEDURES; SCANNING ELECTRON MICROSCOPY; STROMA CELL; TRANSMISSION ELECTRON MICROSCOPY; TUMOR CELL LINE;

ANIMALIA;

CACO-2 CELLS; CELL CULTURE TECHNIQUES; CELL LINE, TUMOR; CELL PROLIFERATION; COCULTURE TECHNIQUES; ENTEROCYTES; EPITHELIAL CELLS; FIBRONECTINS; HT29 CELLS; HUMANS; INSULIN; INTESTINAL ABSORPTION; INTESTINAL MUCOSA; INTESTINES; MICROSCOPY, ELECTRON, SCANNING; MICROSCOPY, ELECTRON, TRANSMISSION; MYOFIBROBLASTS; PERMEABILITY; STROMAL CELLS;

EID: 84928394450     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2015.03.054     Document Type: Article

References (57)

1. Simon-Assman P., Turck N., Sidhoum-Jenny M., Gradwohl G., Kedinger M. Invitro models of intestinal epithelial cell differentiation. Cell Biol Toxicol 2007, 23:241-256.
2. Shah P., Jogani V., Bagchi T., Misra A. Role of Caco-2 cell monolayers in prediction of intestinal drug absorption. Biotechnol Prog 2006, 22:186-198.
3. Hidalgo I.J., Raub T.J., Borchardt R.T. Characterization of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability. Gastroenterology 1989, 96:736-749.
4. Delie F., Rubas W. Ahuman colonic cell line sharing similarities with enterocytes as a model to examine oral absorption: advantages and limitations of the Caco-2 model. Crit Rev Ther Drug Carr Syst 1997, 14:221-286.
5. Sun H., Chow E.C., Liu S., Du Y., Pang K.S. The Caco-2 cell monolayer: usefulness and limitations. Exp Opin Drug Metabol Toxicol 2008, 4:395-411.
6. Press B., Grandi D.D. Permeability for intestinal absorption: Caco-2 assay and related issues. Curr Drug Metabol 2008, 9:893-900.
7. Hilgendorf C., Spahn-Langguth H., Regardh C.G., Lipka E., Amidon G.L., Langguth P. Caco-2 versus Caco-2/HT29-MTX co-cultured cell lines: permeabilities via diffusion, inside- and outside-directed carrier-mediated transport. JPharm Sci 2000, 89:63-75.
8. Beduneau A., Tempesta C., Fimbel S., Pellequer Y., Jannin V., Demarne F., et al. Atunable Caco-2/HT29-MTX co-culture model mimicking variable permeabilities of the human intestine obtained by an original seeding procedure. Eur J Pharm Biopharm 2014, 87(2):290-298.
9. Mahler G.J., Shuler M.L., Glahn R.P. Characterization of Caco-2 and HT29-MTX cocultures in an invitro digestion/cell culture model used to predict iron bioavailability. JNutr Biochem 2009, 20:494-502.
10. Chen X.M., Elisia I., Kitts D.D. Defining conditions for the co-culture of Caco-2 and HT29-MTX cells using Taguchi design. JPharmacol Toxicol Methods 2010, 61:334-342.
11. Justice B.A., Badr N.A., Felder R.A. 3D cell culture opens new dimensions in cell-based assays. Drug Discov Today 2009, 14:102-107.
12. Pampaloni F., Reynaud E.G., Stelzer E.H.K. The third dimension bridges the gap between cell culture and live tissue. Nat Rev Mol Cell Biol 2007, 8:839-845.
13. Shaker A., Rubin D. Intestinal stem cells and epithelial-mesenchymal interactions in the crypt and stem cell niche. Transl Res 2010, 156:180-187.
14. Powell D.W., Adegboyega P.A., Di Mari J.F., Mifflin R.C. Epithelial cells and their neighbors I. Role of intestinal myofibroblasts in development, repair, and cancer. Amer J Physiol Gastroenterol 2005, 289:G2-G7.
15. Joyce N.C., Haire M.F., Palade G.E. Morphologic and biochemical evidence for a contractile cell network within the rat intestinal mucosa. Gastroenterology 1987, 92:68-81.
16. Antunes F., Andrade F., Araújo F., Ferreira D., Sarmento B. Establishment of a triple co-culture invitro cell models to study intestinal absorption of peptide drugs. Eur J Pharm Biopharm 2013, 83:427-435.
17. Araújo F., Sarmento B. Towards the characterization of an invitro triple co-culture intestine cell model for permeability studies. Int J Pharm 2013, 458:128-134.
18. Sarmento B., Ribeiro A., Veiga F., Ferreira D. Development and validation of a rapid reversed-phase HPLC method for the determination of insulin from nanoparticulate systems. Biomed Chromatog 2006, 20:898-903.
19. Green A.J., Yamada K.M. Three-dimensional microenvironments modulate fibroblast signaling responses. Adv Drug Deliv Rev 2007, 59:1293-1298.
20. Hakkinen K.M., Harunaga J.S., Doyle A.D., Yamada K.M. Direct comparisons of the morphology, migration, cell adhesions, and actin cytoskeleton of fibroblasts in four different three-dimensional extracellular matrices. Tissue Eng Part A 2011, 17:713-724.
21. Maia F.R., Lourenço A.H., Granja P.L., Gonçalves R.M., Barrias C.C. Effect of cell density on mesenchymal stem cells aggregation in RGD-alginate 3D matrices under osteoinductive conditions. Macromol Biosci 2014, 14:759-771.
22. Basson M.D., Turowski G., Emenaker N.J. Regulation of human (Caco-2) intestinal epithelial cell differentiation by extracellular matrix proteins. Exp Cell Res 1996, 225:301-305.
23. Adams J.C., Watt F.M. Regulation of development and differentiation by the extracellular matrix. Development 1993, 117:1183-1198.
24. Cukierman E., Pankov R., Stevens D.R., Yamada K.M. Taking cell-matrix adhesions to the third dimension. Science 2001, 294:1708-1712.
25. Artursson P., Palm K., Luthman K. Caco-2 monolayers in experimental and theoretical predictions of drug transport. Adv Drug Deliv Rev 2001, 46:27-43.
26. Furuya S., Furuya K. Subepithelial fibroblasts in intestinal villi: roles in intercellular communication. Int Rev Cytol 2007, 264:165-223.
27. Le Ferrec E., Chesne C., Artusson P., Brayden D., Fabre G., Gires P., et al. Invitro models of the intestinal barrier. The report and recommendations of ECVAM workshop 46. European Centre for the validation of alternative methods. Altern Lab Anim 2001, 29:649-668.
28. Legen I., Salobir M., Kerč J. Comparison of different intestinal epithelia as models for absorption enhancement studies. Int J Pharm 2005, 291:183-188.
29. Wood K.M., Stone G.M., Peppas N.A. The effect of complexation hydrogels on insulin transport in intestinal epithelial cell models. Acta Biomater 2010, 6:48-56.
30. Antunes F., Andrade F., Ferreira D., Nielsen H.M., Sarmento B. Models to predict intestinal absorption of therapeutic peptides and proteins. Curr Drug Metab 2013, 14:4-20.
31. Farquhar M.G., Palade G.E. Junctional complexes in various epithelia. JCell Biol 1963, 17:375-412.
32. Kim Y.S., Ho S.B. Intestinal goblet cells and mucins in health and disease: recent insights and progress. Curr Gastroent Reports 2010, 12:319-330.
33. Bai J.F., Chang L.L. Transepithelial transport of Insulin: I. Insulin degradation by insulin-degrading enzyme in small intestinal epithelium. Pharm Res 1995, 12:1171-1175.
34. Jin Y., Song Y., Zhu X., Zhou D., Chen C., Zhang Z., et al. Goblet cell-targeting nanoparticles for oral insulin delivery and the influence of mucus on insulin transport. Biomaterials 2012, 33:1573-1582.
35. Nelson C.M., Bissell M.J. Of extracellular matrix, scaffolds, and signaling: tissue architecture regulates development, homeostasis, and cancer. Ann Rev Cell Devel Biol 2006, 22:287-309.
36. Fogh J., Orfeo T., Tiso J., Sharkey F.E. Establishment of human colon carcinoma lines in nude mice. Exp Cell Biol 1979, 47:136-144.
37. Puliafito A., Hufnagel L., Neveu P., Streichan S., Sigal A., Fygenson D.K., et al. Collective and single cell behavior in epithelial contact inhibition. PNAS 2012, 109:739-744.
38. Heckman C.A. Contact inhibition revisited. JCell Physiol 2009, 220:574-575.
39. Wells R.G. The role of matrix stiffness in regulating cell behavior. Hepatology 2008, 47:1394-1400.
40. Zaman M.H., Trapani L.M., Sieminski A.L., MacKellar D., Gong H., Kamm R.D., et al. Migration of tumor cells in 3D matrices is governed by matrix stiffness along with cell-matrix adhesion and proteolysis. Proc Natl Acad Sci 2006, 103:10889-10894.
41. Kleinman H.K., Martin G.R. Matrigel: basement membrane matrix with biological activity. Seminars Cancer Biol 2005, 15:378-386.
42. Albini A., Benelli R., Noonan D.M., Brigati C. The "chemoinvasion assay": a tool to study tumor and endothelial cell invasion of basement membranes. Int J Dev Biol 2004, 48:563-571.
43. Li N., Wang D., Sui Z., Qi X., Ji L., Wang X., et al. Development of an improved 3D invitro intestinal mucosa model for drug absorption evaluation. Tissue Eng Part C Methods 2013, 19(9):708-719.
44. Powell D.W., Pinchuk I.V., Saada J.I., Chen X., Mifflin R.C. Mesenchymal cells of the intestinal lamina propria. Ann Rev Physiol 2011, 73:213-237.
45. Yu Q.-H., Yang Q. Diversity of tight junctions (TJs) between gastrointestinal epithelial cells and their function in maintaining the mucosal barrier. Cell Biol Int 2009, 33:78-82.
46. Daugherty A.L., Mrsny R.J. Transcellular uptake mechanisms of the intestinal epithelial barrier part one. Pharm Sci Technol To 1999, 2:144-151.
47. Kavimandan N.J., Peppas N.A. Confocal microscopic analysis of transport mechanisms of insulin across the cell monolayer. Int J Pharm 2008, 354:143-148.
48. Tang C., Yu J., Yin L., Yin C., Pei Y. Transport of insulin in modified Valia-Chien chambers and Caco-2 cell monolayers. Drug Devel Ind Pharm 2007, 33:449-456.
49. Bendayan M., Ziv E., Gingras D., Ben-Sasson R., Bar-On H., Kidron M. Biochemical and morpho-cytochemical evidence for the intestinal absorption of insulin in control and diabetic rats. Comparison between the effectiveness of duodenal and colon mucosa. Diabetologia 1994, 37:119-126.
50. Bendayan M., Ziv E., Ben-Sasson R., Bar-On H., Kidron M. Morpho-cytochemical and biochemical evidence for insulin absorption by the rat ileal epithelium. Diabetologia 1990, 33:197-204.
51. Ziv E., Bendayan M. Intestinal absorption of peptides through the enterocytes. Microsc Res Tech 2000, 49:346-352.
52. Pillion D.J., Ganapathy V., Leibach F.H. Identification of insulin receptors on the mucosal surface of colon epithelial cells. JBiol Chem 1985, 260:5244-5247.
53. Chien Y.W. Human insulin: basic sciences to therapeutic uses. Drug Dev Ind Pharm 1996, 22:753-789.
54. Woitiski C.B., Sarmento B., Carvalho R.A., Neufeld R.J., Veiga F. Facilitated nanoscale delivery of insulin across intestinal membrane models. Int J Pharm 2011, 412:123-131.
55. Yin L., Ding J., Fei L., He M., Cui F., Tang C., et al. Beneficial properties for insulin absorption using superporous hydrogel containing interpenetrating polymer network as oral delivery vehicles. Int J Pharm 2008, 350:220-229.
56. Yin L., Ding J., He C., Cui L., Tang C., Yin C. Drug permeability and mucoadhesion properties of thiolated trimethyl chitosan nanoparticles in oral insulin delivery. Biomaterials 2009, 30:5691-5700.
57. Woitiski C.B., Carvalho R.A., Ribeiro A.J., Neufeld R.J., Veiga F. Strategies toward the improved oral delivery of insulin nanoparticles via gastrointestinal uptake and translocation. BioDrugs 2008, 22:223-237.